Efficacy of Per-oral Methylene Blue Formulation for Screening Colonoscopy
- 1 June 2019
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 156 (8), 2198-2207.e1
- https://doi.org/10.1053/j.gastro.2019.02.001
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer DeathsThe New England Journal of Medicine, 2012
- Prevalence and Variable Detection of Proximal Colon Serrated Polyps During Screening ColonoscopyClinical Gastroenterology and Hepatology, 2011
- High-Definition Chromocolonoscopy vs. High-Definition White Light Colonoscopy for Average-Risk Colorectal Cancer ScreeningThe American Journal of Gastroenterology, 2010
- Quality Indicators for Colonoscopy and the Risk of Interval CancerThe New England Journal of Medicine, 2010
- The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented researchGastrointestinal Endoscopy, 2009
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyGastroenterology, 2008
- A prospective comparative study of narrow-band imaging, chromoendoscopy, and conventional colonoscopy in the diagnosis of colorectal neoplasiaGut, 2007
- Estimates of the cancer incidence and mortality in Europe in 2006Annals Of Oncology, 2007
- Methylene blue but not indigo carmine causes DNA damage to colonocytes in vitro and in vivo at concentrations used in clinical chromoendoscopyGut, 2007
- The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002Gastrointestinal Endoscopy, 2003